Key opinion leader trends, clinical-trial commentary, conference recaps, and AI-native intelligence on the physicians shaping oncology practice — straight from the social conversation.
Blog review of a powerful video discussion by Dr. Marcelo Corassa reviewing the important clinical trials of EGFRmut NSCLC including MARIPOSA and FLAURA2
Lung Cancer Key Opinion Leaders, KOLs, are using memes to communicate the complicated treatment decisions for EGFRmut NSCLC based on the FLAURA2, MARIPOSA
Amid the hype of the plenary session at ASCO23, Dr. Vinay Prasad criticized the study design and ethical implementation of AstraZeneca's ADAURA trial.
KOL Pulse turns the oncology social conversation into AI-native intelligence. See it in action.